A European perspective on immunogenicity evaluation.
Schneider
Christian K
CK
Papaluca
Marisa
M
Kurki
Pekka
P
D000917:Antibody Formation; D001688:Biological Products / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D001709:Biotechnology; D005060:Europe; D017408:Guidelines as Topic; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D018570:Risk Assessment
D001688:Biological Products; D011994:Recombinant Proteins